An adenovirus-based HIV subtype B prime/boost vaccine regimen elicits antibodies mediating broad antibody-dependent cellular cytotoxicity against non-subtype B HIV strains. (Q52840793)
Jump to navigation
Jump to search
scientific article published in November 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An adenovirus-based HIV subtype B prime/boost vaccine regimen elicits antibodies mediating broad antibody-dependent cellular cytotoxicity against non-subtype B HIV strains. |
scientific article published in November 2006 |
Statements
An adenovirus-based HIV subtype B prime/boost vaccine regimen elicits antibodies mediating broad antibody-dependent cellular cytotoxicity against non-subtype B HIV strains. (English)
1 reference
David C Montefiori
1 reference
Marjorie Robert-Guroff
1 reference
V Raúl Gómez-Román
1 reference
Ruth H Florese
1 reference
Bo Peng
1 reference
Vaniambadi S Kalyanaraman
1 reference
David Venzon
1 reference
Indresh Srivastava
1 reference
Susan W Barnett
1 reference
1 November 2006
1 reference
43
1 reference
270-277
1 reference
3
1 reference